BiotechTube

Famotidine Tablets, 40 mg

Phase 1Completed
0 watching 0 views this week💤 Quiet
28
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bioavailability

Conditions

Bioavailability

Trial Timeline

Jun 1, 2004 → —

NCT ID
NCT00803192

About Famotidine Tablets, 40 mg

Famotidine Tablets, 40 mg is a phase 1 stage product being developed by Perrigo for Bioavailability. The current trial status is completed. This product is registered under clinical trial identifier NCT00803192. Target conditions include Bioavailability.

Hype Score Breakdown

Clinical
10
Activity
5
Company
5
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT00803192Phase 1Completed
NCT00802828Phase 1Completed

Competing Products

20 competing products in Bioavailability

See all competitors
ProductCompanyStageHype Score
solifenacin succinate suspension + solifenacin succinate tabletAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
IpragliflozinAstellas PharmaPhase 1
33
HetrombopagJiangsu Hengrui MedicinePhase 1
33
ABT-450/r/ABT-267AbbViePhase 1
33
ABT-333AbbViePhase 1
33
Treatment A- Part 1 + Treatment B- Part 1 + Treatment C - Part 1 + Treatment D- Part 1 + Treatment A-Part 2 + Treatment B - Part 2 + Treatment C - Part 2 + Treatment D - Part 2AstraZenecaPhase 1
33
Naloxegol 25 mg tablet, crushed, suspended in water, given orally + Naloxegol 25mg tablet crushed, suspended in water, given via nasogastric tube + Naloxegol 25 mg (10 mL oral solution) + Naloxegol 25 mg tablet, given orallyAstraZenecaPhase 1
33
selumetinib 75mg single dose + selumetinib 75mg single dose + selumetinib 75mg single doseAstraZenecaPhase 1
33
selumetinib 75mg single doseAstraZenecaPhase 1
33
Ticagrelor 90 mg whole tablet + Ticagrelor 90 mg tablet crushed + Dispersed ticagrelor 90 mg tablet suspended in water - nasogastric tubeAstraZenecaPhase 1
33
AZD5423 + AZD5423 + AZD5423 + AZD5423 + AZD5423 + AZD5423AstraZenecaPhase 1
33
Fostamatinib + Fostamatinib + Fostamatinib + FostamatinibAstraZenecaPhase 1
33
BDA MDI 160/180 mcg + Pulmicort Flexhaler 180 mcgAstraZenecaPhase 1
33
D1400147 + D14000136 + D14000137 + Epanova®AstraZenecaPhase 1
33
Ticagrelor OD tablet (90 mg single dose) administered with 200 ml of water + Ticagrelor OD tablet (90 mg single dose) administered without water + Ticagrelor OD tablet (90 mg single dose) suspended in water administered via nasogastric tube + Brilique®, Ticagrelor IR tablet (90 mg) administered with 200mL of waterAstraZenecaPhase 1
33
NKTR-118 + KetoconazoleAstraZenecaPhase 1
33
TEPEZZA + EDPAmgenPhase 1
32
PF-07321332/ritonavir + PF-07321332/ritonavir + PF-07321332/ritonavir + PF-07321332/ritonavirPfizerPhase 1
32

Other Products from Perrigo

Vivomixx + PlaceboPhase 1/2
36
Naproxen Tablets, 500 mgPhase 1
28
Ibuprofen Tablets, 800 mgPhase 1
28
Naproxen Tablets, 500 mgPhase 1
28
Famotidine Tablets, 40 mgPhase 1
28